Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 8, 2023
PROMIS-29 and EORTC QLQ-C30: an empirical investigation towards a common conception of healthClaudia Hartmann, Felix Fischer, Christoph P Klapproth, et al.
JMIR Cancer|December 22, 2018
Web-Based Patient-Reported Outcomes Using the International Consortium for Health Outcome Measurement Dataset in a Major German University Hospital: Observational StudyMaria M Karsten, Dorothee Speiser, Claudia Hartmann, et al.
Geburtshilfe Und Frauenheilkunde|July 16, 2026
Sexual Distress Scale: Translation, Psychometric Validation, and Reference Values for Cisgender Women and Men in a Representative Population-based Sample in GermanySelina M Kronthaler, Iron J Hahn, Daniel Schulze, et al.
Cancers|June 2, 2021
Measuring Quality of Life Using Patient-Reported Outcomes in Real-World Metastatic Breast Cancer Patients: The Need for a Standardized ApproachMarloes E Clarijs, Jacob Thurell, Friedrich Kühn, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2022
Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patientsMaria M Karsten, Robert Roehle, Sarah Albers, et al.
Breast (Edinburgh, Scotland)|June 9, 2023
Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort studyJacob Thurell, Narges Manouchehri, Irma Fredriksson, et al.
BMC Cancer|January 15, 2025
Incidence of seroma and postoperative complications after breast surgery before and during the Covid-19 pandemic: results from a retrospective multicenter analysisMaximilian Heinz Beck, Izabela A Brachaczek, Pimrapat Gebert, et al.
JAMA Oncology|August 6, 2026
Electronic Patient-Reported Outcome Monitoring With Alert-Based Interventions in Metastatic Breast Cancer: A Randomized Clinical TrialMaria M Karsten, Pimrapat Gebert, Therese Pross, et al.
Molecular Cancer Research : MCR|October 26, 2018
Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast CancerAhmed Basudan, Nolan Priedigkeit, Ryan J Hartmaier, et al.
NPJ Breast Cancer|July 3, 2019
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtypeKevin M Levine, Nolan Priedigkeit, Ahmed Basudan, et al.
Pageof 2